BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25956670)

  • 1. Prenatal therapy in transient abnormal myelopoiesis: a systematic review.
    Tamblyn JA; Norton A; Spurgeon L; Donovan V; Bedford Russell A; Bonnici J; Perkins K; Vyas P; Roberts I; Kilby MD
    Arch Dis Child Fetal Neonatal Ed; 2016 Jan; 101(1):F67-71. PubMed ID: 25956670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
    Nakashima MO; Shetty S; Chicka M; Flagg A; Eng C; Cotta CV
    Pediatr Blood Cancer; 2015 Feb; 62(2):353-355. PubMed ID: 25175265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
    Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
    Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.
    Corazza F; Astolfi A; Libri V; Franzoni M; Serravalle S; Alessandroni R; Melchionda F; Pession A
    Int J Hematol; 2014 Jun; 99(6):794-7. PubMed ID: 24771229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of transient abnormal myelopoiesis in three fetuses with Down syndrome: heterogeneous ultrasonographic findings and outcomes.
    Rizzo A; Perotti G; Fiandrino G; Spinillo A; Stronati M; Iasci A
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):412-413. PubMed ID: 28600809
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
    Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
    Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS).
    Al-Kershi S; Golnik R; Flasinski M; Waack K; Rasche M; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Klin Padiatr; 2021 Nov; 233(6):267-277. PubMed ID: 34407551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
    Kuo E; Kumarapeli AR
    Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive and inexpensive high-resolution melting-based testing algorithm for diagnosis of transient abnormal myelopoiesis and myeloid leukemia of Down syndrome.
    Camargo R; de Castro Moreira Dos Santos A; Cândido Guido B; Lemos Mendanha Cavalcante L; Silva Dias AC; Mendonça de Pontes R; Magalhães Furtado F; Feitosa Salviano C; Tiziani V; Martins Córdoba JC; Quezado Magalhães IM
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29866. PubMed ID: 35731576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
    Watanabe K
    Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
    Miyauchi J
    Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome.
    Tunstall O; Bhatnagar N; James B; Norton A; O'Marcaigh AS; Watts T; Greenough A; Vyas P; Roberts I; Wright M;
    Br J Haematol; 2018 Jul; 182(2):200-211. PubMed ID: 29916557
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
    Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
    Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient abnormal myelopoiesis associated with Down syndrome presenting as severe hydrops fetalis: a case report.
    Malin GL; Kilby MD; Velangi M
    Fetal Diagn Ther; 2010; 27(3):171-3. PubMed ID: 20160425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome.
    Saida S; Watanabe K; Sato-Otsubo A; Terui K; Yoshida K; Okuno Y; Toki T; Wang R; Shiraishi Y; Miyano S; Kato I; Morishima T; Fujino H; Umeda K; Hiramatsu H; Adachi S; Ito E; Ogawa S; Ito M; Nakahata T; Heike T
    Blood; 2013 May; 121(21):4377-87. PubMed ID: 23482930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient leukemia in a newborn without Down syndrome: case report and review of the literature.
    Rozen L; Huybrechts S; Dedeken L; Heijmans C; Dessars B; Heimann P; Lambert F; Noubouossie DF; Ferster A; Demulder A
    Eur J Pediatr; 2014 Dec; 173(12):1643-7. PubMed ID: 24253371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
    Lum SH; Choong SS; Krishnan S; Mohamed Z; Ariffin H
    Singapore Med J; 2016 Jun; 57(6):320-4. PubMed ID: 27353457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis.
    Minakata S; Sakata N; Wada N; Konishi Y; Marutani S; Enya T; Nakagawa H; Wada H; Takemura T
    Pediatr Int; 2016 Nov; 58(11):1222-1225. PubMed ID: 27709778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21.
    Aksu T; Gümrük F; Ünal Ş
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28289. PubMed ID: 32725847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.